Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis Post author:Sam Post published:February 12, 2018 Post category:BioPharma That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace You Might Also Like Agios, Celgene Win Early FDA Approval for New Cancer Drug July 31, 2017 Check-Cap Reports First Quarter 2017 Financial Results May 8, 2017 WuXi AppTec Lab Testing Division's Analytical And Stability Testing Facilities Passed FDA Inspection April 11, 2016
WuXi AppTec Lab Testing Division's Analytical And Stability Testing Facilities Passed FDA Inspection April 11, 2016